Skip to main content

WHY IT MATTERS

BIOBANKING SERVICES

The gap between what we know and what we do is one of the largest remediable sources of preventable harm in medicine.

~17 years

The frequently cited estimate for the lag between research evidence and routine clinical practice

(Balas & Boren 2000)

A Fraction

Of original discoveries ever reach day-to-day care at all — and the lag itself resist a single robust number

(Morris, Wooding, & Grant 2011)

Wide

Unexplained geographic and between-site variation in practice and outcomes for identical conditions

(Dartmouth Atlas Tradition)

Those numbers describe a translational failure, not a knowledge failure. We generate an enormous amount of evidence; we are slow and uneven at putting it to work. A Learning Health System is the organizational answer to that problem — infrastructure that shortens the distance between a finding and a change in care, and then measures whether the change helped.

Five reasons the model earns its keep

  • Speed. Evidence that takes years to diffuse can, in a functioning LHS, move into an order set or pathway in weeks — with the effect measured rather than assumed.
  • Relevance. Classical trials answer questions about carefully selected populations. Real-world data answers questions about the patients actually in front of us, including rural, Native American, Hispanic/Latino, and border communities that are under-represented in registration trials.
  • Efficiency. When learning is embedded in operations, evidence generation becomes a by-product of care rather than a separate, expensively duplicated enterprise.
  • Equity. Systematic self-study surfaces disparities that averages hide — who is getting the guideline-concordant care and who is not.
  • Accountability. Health systems are increasingly asked to demonstrate value. An LHS produces the evidence that a change actually improved outcomes, and detects unintended consequences early.

What each side gains

For the health systemFor the research community
Rigorous, timely evaluation of QI and standardization initiativesAccess to real-world data and to the populations that most need answers
Early detection of unintended consequences and site-level variationA route for findings to reach practice instead of stopping at publication
Analytic capacity that operational teams rarely have bandwidth to buildPragmatic trial and embedded-research opportunities at scale
A pipeline of clinically fluent data scientists and informaticiansQuestions shaped by the people who will have to act on the answers
External funding that supports internal quality goalsA durable partnership rather than a one-off data request